Endocyte (ECYT) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. ARM
5. EXPE
6. QCOM
7. DDOG
8. CHYM
9. CPAY
10. PAYC

Go back to Endocyte (ECYT) Tops Q4 EPS by 4c

Wedbush Cuts Price Target on Endocyte (ECYT) as Expected Approval Times are Pushed Back

March 3, 2016 7:53 AM EST

Wedbush maintained an Outperform rating on Endocyte (NASDAQ: ECYT), and cut the price target to $8.00 (from $12.00), following the company's 4Q. Dose-escalation continues in the Ph 1 studies of EC1456 and EC1169 as MTD has not yet been reached. Once MTD is reached the EC1456 study will enroll up to 40 second-line folate-receptor positive NSCLC... More